Cover: Playing God?

Playing God?

Media Coverage of CRISPR in the United States

Published in: Public Understanding of Science, Volume 32, Issue 4, pages 504–521 (May 2023). doi: 10.1177/09636625221138953

Posted on Nov 8, 2023

by Patricia A. Stapleton, Alessandra Torres Yabar

Announcements in 2017 and 2018 that scientists used a gene editing technique called Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) to permanently alter human embryos have highlighted the urgency in regulating the technology's ethical, political, and legal implications. To better understand how a regulatory regime might evolve in response to CRISPR, we must examine how the media covers it. This article reviews online and television news sources in the United States to determine the tone, content, and frequency in media coverage of CRISPR. We find that coverage remained ambiguous and infrequent, as scientific research into CRISPR's clinical potential for treating human disease surged. This infrequent coverage indicates that the media have not yet established the salience of CRISPR to a degree that engages the public or policymakers, though the issue will continue to gain importance as CRISPR transitions from experimental efforts into clinical practice.

Research conducted by

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.